National report — A proposed $3.2 billion merger of Botox-maker Allergan and breast-implant maker Inamed would ultimately benefit dermatologists, an Allergan official says.
Hyaluronic Acid-Based Fillers Effective in Treating Signs of Aging
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
Periorbital Rejuvenation: Comprehensive Assessment and Product Choice Are Key to Results
The Cutaneous Connection: Cosmetic Dermatology: Procedures and Practice
Understanding the Role of Amino Acids and Proteins in Skin Care
First Patient Dosed in Phase 2 Trial of Bempikibart for Alopecia Areata